As specialty medicines account for an increasing share of the drug pipeline, it makes sense for sponsors to support patients financially, emotionally and logistically.

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. By Ellen Gabler Soon after being diagnosed with metastatic breast ...